Skip to main content
The MattCorc Podcast

The MattCorc Podcast

By Life Sciences Rush Hour
A daily, 5-10 minute, podcast where we talk about risk and investing. Find out more at or shoot me an email at I would love to hear any feedback, including topic suggestions and insurance questions. If you would like to join me on an episode, send me an email.
Listen on
Where to listen
Apple Podcasts Logo

Apple Podcasts

Breaker Logo


Castbox Logo


Google Podcasts Logo

Google Podcasts

Overcast Logo


Pocket Casts Logo

Pocket Casts

RadioPublic Logo


Spotify Logo


Currently playing episode

Medtech Conference 2018

The MattCorc Podcast

Where does the market go from here? Will retail investors sell?
We talk about the recent market turmoil and how that will impact investor actions. Will investors stick to their guns or succumb and sell if the market continues to sell off. A few comments on Medtronic’s settlement and how insurance could have been implemented to reduce the financial burden for Medtronic.
November 21, 2018
What’s the deal with GE?
GE has seen its market cap decrease by over $200B since 2016 and it now trades at around $8. Is this the correct value or should it be higher or perhaps lower?
November 16, 2018
We changed our name and Amazon announced their new locations!
Why we changed our name to the MattCorc Podcast. Who is taking the most risk with the Amazon headquarters, Amazon or the local/state government? What is Waymo? The first autonomous ride hailing service is getting ready to launch in Arizona.
November 14, 2018
A $500 Million Biotech IPO. Amarin Data
Moderna plans the biggest biotech IPO ever and we learn more about Amarin’s clinical study. Was mineral oil the best choice of placebo? Lessons we can learn from Amarin about D&O insurance.
November 12, 2018
Herd Mentality. Why D&O benchmarking is a sales ploy. What to use to make a more informed decision.
I talk about how brokers use benchmarking to sell you more D&O insurance. Brokers take advantage of herd mentality so insurers buy more D&O than they need.
November 9, 2018
Why cost should only be one consideration
Cost and its importance are discussed. Minor differences in coverage can cause major headaches when you have a claim.
November 6, 2018
S&P Companies not as negative; Gene Therapy manufacturing is stretched thin
Happy national doughnut day! Fewer companies in the S&P are providing negative guidance. What does this mean? How CFOs are protecting their balance sheets in the event their manufacturing is disrupted.
November 5, 2018
Lessons from Halloween when your kids have peanut allergies
Why is Aimmune (AIMT) up today? Is it because Halloween reminded investors how many types of candy have peanuts in them? A lesson on how to make sure you aren’t missing significant coverage gaps in your insurance program. Hint: I learned it from checking my kids Halloween candy.
November 1, 2018
Swimming and the Dow Jones
How my first time swimming in a lap pool in years was a good metaphor for today’s market and some other interesting facts on the financial markets.
October 29, 2018
President’s Drug Pricing Speech and New CA Sexual Harassment Law
An overview of the President’s drug pricing proposal and what the new California sexual harassment law could mean for your insurance.
October 25, 2018
M&A Activity - Will Market Forces Play a Role?
With biotech stocks sinking, the XBI just hit a 52 week low, and interest rates rising will we see an urgency for acquisitions to be done?
October 24, 2018
Episode 36 - Concept or Concrete?
Quick post on why Insurance buying doesn’t need to be so abstract.
October 19, 2018
Episode 35 - McDermott Will & Emery Dealmaking Symposium Recap
A ton was learned at the MWE life science deal making symposium and here I share that with you.
October 18, 2018
Episode 34 - DeviceTalks Recap
A synopsis of DeviceTalks Boston. Pathways to acquisition, hurdles that you might face and how to derisk your company to make it more appealing to investors and acquiring companies.
October 17, 2018
Episode 33 - Chinese Espionage and Cyber Coverage
What can we learn from the alleged Chinese cyber espionage incident and how cyber insurance could respond.
October 4, 2018
Episode 32 - Can the Biotech IPO Market Sustain Itself?
I would love to hear whether people believe the pace of biotech IPOs will continue. Hear my thoughts and share yours at
October 3, 2018
I’m Doing an IPO and My D&O Insurance is Expensive
Why D&O Insurance is expensive for life science companies and how the stage your company is in impacts pricing.
October 1, 2018
FDA Condemns Undamaged Product - Insurance Should Have Paid
A client had a fire and $250,000 in product was destroyed. Undamaged condemned stock was valued at over $500,000 but there insurance did not cover it. Find out why that should never happen.
September 25, 2018
Episode 29 - MD Bio-Tech Conference Recap
A recap of the Maryland Bio-Tech Conference that I recently attended.
September 21, 2018
Episode 28 - NJTC CFO Forum Recap
A recap of the CFO Forum put on by the NJ Tech Council. The speaker was Jim Mastakas who was the CFO of Amneal when they merged with Impax Labs
September 19, 2018
Episode 27 - Monday Market Update
The impacts of Hurricane Florence on the property insurance market are discussed
September 17, 2018
Common Question Friday #1
Why does a pre-clinical company need insurance?
September 14, 2018
Apple Watch, Transitioning From Digital Health to Med Device
A quick synopsis of how insurance liability changes as a company enters the realm to an FDA regulated product.
September 13, 2018
Hurricane Florence and Where to Look for Property Coverage
Where to look for additional coverage in your proprty policy above and beyond replacing your building or contents. Things to be aware of that could reduce coverage.
September 12, 2018
Abbvie Testosterone Settlement and Product Liability
I discuss the Abbvie testosterone settlement and the role of product liability insurance could play. Hurricanes and property insurance.
September 11, 2018
Episode 22 - Boston Biotech Week and RESI
A recap of Boston Biotech Week and the RESI conference. How insurance can help you stand out with investors.
September 10, 2018
Episode 21 - Patent Insurance...It’s a Real Thing
An overview of patent insurance and what it can do.
August 30, 2018
Episode 20 - Opioid Settlement and Product Liability
A discussion on Product Liability insurance in relation to a possible opioid settlement. Wage & Hour lawsuits are on the rise but there is a solution.
August 29, 2018
What happens when your supply chain is disrupted?
In the wake of an API manufacturer being shut down in China I discuss using insurance to mitigate the cash flow disruption.
August 24, 2018
Should Public Companies Only Report Earnings Semi-Annually?
The possible impacts on moving from quarterly to semiannual reporting periods for public companies on the D&O insurance marketplace
August 23, 2018
Episode 17 - Getting Your Product Approved
Amicus and Alnylam both got FDA approval last week. Find out how that can change their risk profile.
August 14, 2018
Cyber Insurance - Is Change Coming?
I discuss the PGA Championship being cyber extorted, CA Consumer Privacy Act and the role insurance plays in both of these events.
August 9, 2018
Apple, AIG, D&O Insurance and Patents
We discuss Apple hitting the $1 trillion mark, AIG going the other way, government taking your patent and D&O insurance
August 2, 2018
Episode 14 - Securities Class Action Filings and D&O Cover
I talk about the prevalence of securities class action filings and how D&O can protect you. I also discuss how we should not choose limits solely by what our peers have in place.
July 31, 2018
Episode 13 - Sarepta and Insuring Regulatory Risk
I talk about what we can learn from Sarepta's clinical hold and how they could insure such an event for their commercial product.
July 26, 2018
Episode 12
July 25, 2018
Keryx Merger and Supply Chain issues
Today we are reminded, due to the news that Keryx and Akebia are merging, of what happens when you have a supply chain issue.
June 28, 2018
Insuring the Black Swan
Aquinox disaster and what you can do to protect your company from Black Swans.
June 27, 2018
Stryker Acquisition, CRISPR problems
Recap of today’s big events. Stryker bidding on Boston Scientific. CRISPR might cause cancer.
June 11, 2018
Liability for Digital Health Products
I discuss liability when a digital health product works but something bad happens. Blurring the lines of medtech and digital health.
June 5, 2018
Medtech Conference 2018
A brief review of the 2018 Medtech conference in Minneapolis
June 4, 2018
Episode 6 - IPO and D&O
IPO market is healthy. Rockwell Medical and how D&O insurance could provide balance sheet protection
May 25, 2018
Episode 5 - Keytruda, Rockwell Medical, Spoilage
Keytruda does it again in the clinic and also changes to M&A landscape. What’s going on at Rockwell Medical? Is your product temperature sensitive?
May 23, 2018
Episode 4 - FDA and Hemophilia
Quick rundown on FDA related news, Hemophilia news and how right to try could impact the insurance market
May 22, 2018
May 17, 2018
May 17, 2018
May 15, 2018
May 15, 2018
May 11, 2018
Episode 1 - Drug Pricing and Ford
May 14, 2018